An experimental strategy to probe Gq contribution to signal transduction in living cells

[1]  A. Lyon,et al.  Q's the Boss: Gαq Regulates Gi-Mediated Calcium Release through PLCβ. , 2020, Molecular cell.

[2]  B. Fleischmann,et al.  Heterotrimeric G Protein Subunit Gαq Is a Master Switch for Gβγ-Mediated Calcium Mobilization by Gi-Coupled GPCRs. , 2020, Molecular cell.

[3]  Xianqun Fan,et al.  Uveal melanoma: progress in molecular biology and therapeutics , 2020, Therapeutic advances in medical oncology.

[4]  E. Gaffal.  Research in practice: Therapeutic targeting of oncogenic GNAQ mutations in uveal melanoma , 2020, Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG.

[5]  M. Nasrullah,et al.  Functional Evidence for Biased Inhibition of G protein Signaling by YM-254890 in Human Coronary Artery Endothelial Cells , 2020, bioRxiv.

[6]  David E. Gloriam,et al.  Delineation of molecular determinants for FR900359 inhibition of Gq/11 unlocks inhibition of Gαs , 2020, The Journal of Biological Chemistry.

[7]  H. Othmer,et al.  The Roles of Signaling in Cytoskeletal Changes, Random Movement, Direction-Sensing and Polarization of Eukaryotic Cells , 2020, Cells.

[8]  E. Kostenis,et al.  Heterotrimeric Gq proteins as therapeutic targets? , 2020, The Journal of Biological Chemistry.

[9]  C. Müller,et al.  Cell‐permeable high‐affinity tracers for Gq proteins provide structural insights, reveal distinct binding kinetics and identify small molecule inhibitors , 2019, British journal of pharmacology.

[10]  U. Stochaj,et al.  The Cytoskeleton as Regulator of Cell Signaling Pathways. , 2019, Trends in biochemical sciences.

[11]  E. Kostenis,et al.  Chemokine receptor trafficking coordinates neutrophil clustering and dispersal at wounds in zebrafish , 2019, Nature Communications.

[12]  E. Kostenis,et al.  Activation of Gq signaling by Pasteurella multocida toxin inhibits the osteoblastogenic-like actions of Activin A in C2C12 myoblasts, a cell model of fibrodysplasia ossificans progressiva. , 2019, Bone.

[13]  Robert B. Russell,et al.  Illuminating the Onco-GPCRome: Novel G protein–coupled receptor-driven oncocrine networks and targets for cancer immunotherapy , 2019, The Journal of Biological Chemistry.

[14]  S. Ferrini,et al.  Targeted Therapy of Uveal Melanoma: Recent Failures and New Perspectives , 2019, Cancers.

[15]  L. Pott,et al.  Biased signaling of Ca2+-sensing receptors in cardiac myocytes regulates GIRK channel activity. , 2019, Journal of molecular and cellular cardiology.

[16]  P. Kolb,et al.  Direct targeting of Gαq and Gα11 oncoproteins in cancer cells , 2019, Science Signaling.

[17]  D. Gloriam,et al.  Rational design of a heterotrimeric G protein α subunit with artificial inhibitor sensitivity , 2019, The Journal of Biological Chemistry.

[18]  A. Aplin,et al.  Effects of Oncogenic Gαq and Gα11 Inhibition by FR900359 in Uveal Melanoma , 2018, Molecular Cancer Research.

[19]  E. Kostenis,et al.  Gβγ signaling to the chemotactic effector P-REX1 and mammalian cell migration is directly regulated by Gαq and Gα13 proteins , 2018, The Journal of Biological Chemistry.

[20]  Oscar M. Bautista-Aguilera,et al.  Label-Free Whole Cell Biosensing for High-Throughput Discovery of Activators and Inhibitors Targeting G Protein-Activated Inwardly Rectifying Potassium Channels , 2018, ACS omega.

[21]  T. Huber,et al.  G protein subtype–specific signaling bias in a series of CCR5 chemokine analogs , 2018, Science Signaling.

[22]  A. Smrcka,et al.  Targeting G protein-coupled receptor signalling by blocking G proteins , 2018, Nature Reviews Drug Discovery.

[23]  J. Cooper,et al.  Targeting nucleotide exchange to inhibit constitutively active G protein α subunits in cancer cells , 2018, Science Signaling.

[24]  E. Kostenis,et al.  RXFP1 Receptor Activation by Relaxin-2 Induces Vascular Relaxation in Mice via a Gαi2-Protein/PI3Kß/γ/Nitric Oxide-Coupled Pathway , 2018, Front. Physiol..

[25]  M. Ayoub.  Small molecules targeting heterotrimeric G proteins , 2018, European journal of pharmacology.

[26]  S. Bird.  Calcium mediates cell shape change in human peritoneal mesothelial cells. , 2018, Cell calcium.

[27]  C. Müller,et al.  Heterologous Expression, Biosynthetic Studies, and Ecological Function of the Selective Gq-Signaling Inhibitor FR900359. , 2018, Angewandte Chemie.

[28]  K. Jacobson,et al.  On the G protein‐coupling selectivity of the native A2B adenosine receptor , 2017, Biochemical pharmacology.

[29]  J. Wess,et al.  Lack of beta-arrestin signaling in the absence of active G proteins , 2018, Nature Communications.

[30]  I. Hall,et al.  Targeted inhibition of Gq signaling induces airway relaxation in mouse models of asthma , 2017, Science Translational Medicine.

[31]  Vaishali V. Inamdar,et al.  Gq pathway regulates proximal C-type lectin-like receptor-2 (CLEC-2) signaling in platelets , 2017, The Journal of Biological Chemistry.

[32]  P. Osei-Owusu,et al.  Functional Mechanisms of Novel G Protein Inhibitor Ligands As Vasodilators , 2017 .

[33]  R. Sommese,et al.  Priming GPCR signaling through the synergistic effect of two G proteins , 2017, Proceedings of the National Academy of Sciences.

[34]  R. Thakker,et al.  Knockin mouse with mutant Gα11 mimics human inherited hypocalcemia and is rescued by pharmacologic inhibitors. , 2017, JCI insight.

[35]  M. Olianas,et al.  Protection from interferon‐β‐induced neuronal apoptosis through stimulation of muscarinic acetylcholine receptors coupled to ERK1/2 activation , 2016, British journal of pharmacology.

[36]  Ashley M. Miller,et al.  A Novel Allosteric Activator of Free Fatty Acid 2 Receptor Displays Unique Gi-functional Bias* , 2016, The Journal of Biological Chemistry.

[37]  K. Jacobson,et al.  On the selectivity of the Gαq inhibitor UBO-QIC: A comparison with the Gαi inhibitor pertussis toxin. , 2016, Biochemical pharmacology.

[38]  Q. Ma,et al.  Human Neuropeptide S Receptor Is Activated via a Gαq Protein-biased Signaling Cascade by a Human Neuropeptide S Analog Lacking the C-terminal 10 Residues* , 2016, The Journal of Biological Chemistry.

[39]  Sung Hye Kim,et al.  The oxytocin receptor antagonist, Atosiban, activates pro-inflammatory pathways in human amnion via Gαi signalling , 2016, Molecular and Cellular Endocrinology.

[40]  J. Benovic,et al.  Interdicting Gq Activation in Airway Disease by Receptor-Dependent and Receptor-Independent Mechanisms , 2016, Molecular Pharmacology.

[41]  M. Macías-Silva,et al.  GPCRs and actin-cytoskeleton dynamics. , 2016, Methods in cell biology.

[42]  H. Dohlman,et al.  The experimental power of FR900359 to study Gq-regulated biological processes , 2015, Nature Communications.

[43]  M. Cobb,et al.  Differential Regulation of ERK1/2 and mTORC1 Through T1R1/T1R3 in MIN6 Cells. , 2015, Molecular endocrinology.

[44]  Ravi Iyengar,et al.  Can intracellular cAMP dynamics enable scalable computation? , 2015, Front. Cell. Neurosci..

[45]  Vaishali V. Inamdar,et al.  Characterization of UBO-QIC as a Gαq inhibitor in platelets , 2015, Platelets.

[46]  E. Kostenis,et al.  Label-free biosensor assays in GPCR screening. , 2015, Methods in molecular biology.

[47]  J. Tesmer,et al.  Molecular mechanisms of phospholipase C β3 autoinhibition. , 2014, Structure.

[48]  J. Sondek,et al.  Membrane-induced Allosteric Control of Phospholipase C-β Isozymes* , 2014, The Journal of Biological Chemistry.

[49]  U. Holzgrabe,et al.  A cell-permeable inhibitor to trap Gαq proteins in the empty pocket conformation. , 2014, Chemistry & biology.

[50]  S. Brothers,et al.  Differential Effects of the Gβ5-RGS7 Complex on Muscarinic M3 Receptor–Induced Ca2+ Influx and Release , 2014, Molecular Pharmacology.

[51]  Alex R. B. Thomsen,et al.  Delineation of the GPRC6A Receptor Signaling Pathways Using a Mammalian Cell Line Stably Expressing the Receptor , 2013, The Journal of Pharmacology and Experimental Therapeutics.

[52]  Daniel Schulz,et al.  Decoding Signaling and Function of the Orphan G Protein–Coupled Receptor GPR17 with a Small-Molecule Agonist , 2013, Science Signaling.

[53]  H. Hamm,et al.  Conformational flexibility and structural dynamics in GPCR-mediated G protein activation: a perspective. , 2013, Journal of molecular biology.

[54]  A. Smrcka.  Molecular targeting of Gα and Gβγ subunits: a potential approach for cancer therapeutics. , 2013, Trends in pharmacological sciences.

[55]  E. Ross,et al.  Mammalian phospholipase C. , 2013, Annual review of physiology.

[56]  Sun-Gu Lee,et al.  A Study on the Effect of Surface Lysine to Arginine Mutagenesis on Protein Stability and Structure Using Green Fluorescent Protein , 2012, PloS one.

[57]  Kevin W Eliceiri,et al.  NIH Image to ImageJ: 25 years of image analysis , 2012, Nature Methods.

[58]  H. Dohlman,et al.  Signal Activation and Inactivation by the Gα Helical Domain: A Long-Neglected Partner in G Protein Signaling , 2012, Science Signaling.

[59]  G. Guillon,et al.  Engagement of β-arrestin by transactivated insulin-like growth factor receptor is needed for V2 vasopressin receptor-stimulated ERK1/2 activation , 2012, Proceedings of the National Academy of Sciences.

[60]  G. Milligan,et al.  Applying label-free dynamic mass redistribution technology to frame signaling of G protein–coupled receptors noninvasively in living cells , 2011, Nature Protocols.

[61]  E. Trinquet,et al.  Monitoring Gq-coupled receptor response through inositol phosphate quantification with the IP-One assay , 2011, Expert opinion on drug discovery.

[62]  Stephanie N. Hicks,et al.  Direct Activation of Human Phospholipase C by Its Well Known Inhibitor U73122* , 2011, The Journal of Biological Chemistry.

[63]  D. Cooper,et al.  Regulation by Ca2+-signaling pathways of adenylyl cyclases. , 2011, Cold Spring Harbor perspectives in biology.

[64]  F. Fan,et al.  Luciferase Reporter Assay System for Deciphering GPCR Pathways , 2010, Current chemical genomics.

[65]  M. Simon,et al.  Synergistic Ca2+ Responses by Gαi- and Gαq-coupled G-protein-coupled Receptors Require a Single PLCβ Isoform That Is Sensitive to Both Gβγ and Gαq* , 2010, The Journal of Biological Chemistry.

[66]  G. Milligan,et al.  Deconvolution of complex G protein–coupled receptor signaling in live cells using dynamic mass redistribution measurements , 2010, Nature Biotechnology.

[67]  Y. Obara,et al.  P2Y2 Receptor-Gq/11 Signaling at Lipid Rafts Is Required for UTP-Induced Cell Migration in NG 108-15 Cells , 2010, Journal of Pharmacology and Experimental Therapeutics.

[68]  E. Ross,et al.  Synergistic Activation of Phospholipase C-β3 by Gαq and Gβγ Describes a Simple Two-State Coincidence Detector , 2010, Current Biology.

[69]  T. Hakoshima,et al.  Structural basis for the specific inhibition of heterotrimeric Gq protein by a small molecule , 2010, Proceedings of the National Academy of Sciences.

[70]  J. McCarron,et al.  The phospholipase C inhibitor U‐73122 inhibits Ca2+ release from the intracellular sarcoplasmic reticulum Ca2+ store by inhibiting Ca2+ pumps in smooth muscle , 2010, British journal of pharmacology.

[71]  C. Hertel,et al.  Screening a Plant Extract Library for Inhibitors of Cholecystokinin Receptor CCK1 Pathways , 2010, Journal of biomolecular screening.

[72]  O. De Wever,et al.  Inhibition of Heterotrimeric G Protein Signaling by a Small Molecule Acting on Gα Subunit , 2009, The Journal of Biological Chemistry.

[73]  L. Pardo,et al.  The C-terminal Tail of CRTH2 Is a Key Molecular Determinant That Constrains Gαi and Downstream Signaling Cascade Activation* , 2009, Journal of Biological Chemistry.

[74]  Carmen W. Dessauer,et al.  Physiological Roles for G Protein-Regulated Adenylyl Cyclase Isoforms: Insights from Knockout and Overexpression Studies , 2008, Neurosignals.

[75]  Andrew J. Murray.  Pharmacological PKA Inhibition: All May Not Be What It Seems , 2008, Science Signaling.

[76]  H. Hamm,et al.  Heterotrimeric G protein activation by G-protein-coupled receptors , 2008, Nature Reviews Molecular Cell Biology.

[77]  Mindy I. Davis,et al.  A quantitative analysis of kinase inhibitor selectivity , 2008, Nature Biotechnology.

[78]  D. Clapham,et al.  Calcium Signaling , 2007, Cell.

[79]  P. Marin,et al.  GPCR-jacking: from a new route in RTK signalling to a new concept in GPCR activation. , 2007, Trends in pharmacological sciences.

[80]  H. Kovacic,et al.  G␣(q/11)-coupled P2y 2 Nucleotide Receptor Inhibits Human Keratinocyte Spreading and Migration , 2022 .

[81]  A. Whitmarsh.  Regulation of gene transcription by mitogen-activated protein kinase signaling pathways. , 2007, Biochimica et biophysica acta.

[82]  D. Siderovski,et al.  Receptor-Mediated Activation of Heterotrimeric G-Proteins: Current Structural Insights , 2007, Molecular Pharmacology.

[83]  Andreas Bender,et al.  Understanding False Positives in Reporter Gene Assays: in Silico Chemogenomics Approaches To Prioritize Cell-Based HTS Data , 2007, J. Chem. Inf. Model..

[84]  A. Turjanski,et al.  MAP kinases and the control of nuclear events , 2007, Oncogene.

[85]  H. Kovacic,et al.  G alpha(q/11)-coupled P2Y2 nucleotide receptor inhibits human keratinocyte spreading and migration. , 2007, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[86]  J. Pin,et al.  D-myo-inositol 1-phosphate as a surrogate of D-myo-inositol 1,4,5-tris phosphate to monitor G protein-coupled receptor activation. , 2006, Analytical biochemistry.

[87]  M. Taniguchi,et al.  Biological properties of a specific Gαq/11 inhibitor, YM‐254890, on platelet functions and thrombus formation under high‐shear stress , 2006, British journal of pharmacology.

[88]  M. Taniguchi,et al.  Effect of YM-254890, a specific Galphaq/11 inhibitor, on experimental peripheral arterial disease in rats. , 2006, European journal of pharmacology.

[89]  G. Milligan,et al.  Heterotrimeric G‐proteins: a short history , 2006, British journal of pharmacology.

[90]  Z. Vogel,et al.  Adenylyl cyclase type-VIII activity is regulated by Gβγ subunits , 2006 .

[91]  Z. Vogel,et al.  Adenylyl cyclase type-VIII activity is regulated by G(betagamma) subunits. , 2006, Cellular signalling.

[92]  B. Berk,et al.  Crosstalk coregulation mechanisms of G protein-coupled receptors and receptor tyrosine kinases. , 2006, Methods in molecular biology.

[93]  M. Taniguchi,et al.  [Pharmacological properties of a specific Gq/11 inhibitor, YM-254890]. , 2006, Nihon yakurigaku zasshi. Folia pharmacologica Japonica.

[94]  Stefan Offermanns,et al.  Mammalian G proteins and their cell type specific functions. , 2005, Physiological reviews.

[95]  Ye Fang,et al.  Probing cytoskeleton modulation by optical biosensors , 2005, FEBS letters.

[96]  M. Taniguchi,et al.  A Novel Gαq/11-selective Inhibitor* , 2004, Journal of Biological Chemistry.

[97]  T. Patel,et al.  Single Transmembrane Spanning Heterotrimeric G Protein-Coupled Receptors and Their Signaling Cascades , 2004, Pharmacological Reviews.

[98]  B. H. Shah,et al.  GPCR-mediated transactivation of RTKs in the CNS: mechanisms and consequences , 2004, Trends in Neurosciences.

[99]  S. Offermanns,et al.  Mouse models to study G-protein-mediated signaling. , 2004, Pharmacology & therapeutics.

[100]  M. Taniguchi,et al.  A novel Galphaq/11-selective inhibitor. , 2004, The Journal of biological chemistry.

[101]  Andrew D Sharrocks,et al.  Transcriptional regulation by the MAP kinase signaling cascades. , 2003, Gene.

[102]  D. Cooper.  Regulation and organization of adenylyl cyclases and cAMP. , 2003, The Biochemical journal.

[103]  Stefan Offermanns,et al.  G-proteins as transducers in transmembrane signalling. , 2003, Progress in biophysics and molecular biology.

[104]  J. Dunlop,et al.  Evaluation of FLIPR Calcium 3 Assay Kit—A New No-Wash Fluorescence Calcium Indicator Reagent , 2003, Journal of biomolecular screening.

[105]  M. Taniguchi,et al.  Antithrombotic and thrombolytic efficacy of YM-254890, a Gq/11 inhibitor, in a rat model of arterial thrombosis , 2003, Thrombosis and Haemostasis.

[106]  Andreas Sewing,et al.  Measuring intracellular calcium fluxes in high throughput mode. , 2003, Combinatorial chemistry & high throughput screening.

[107]  M. Taniguchi,et al.  YM-254890, a novel platelet aggregation inhibitor produced by Chromobacterium sp. QS3666. , 2003, The Journal of antibiotics.

[108]  Prahlad T. Ram,et al.  G Protein Pathways , 2002, Science.

[109]  N. Ip,et al.  Integration of Signals from Receptor Tyrosine Kinases and G Protein-Coupled Receptors , 2002, Neurosignals.

[110]  M. Karin,et al.  Mammalian MAP kinase signalling cascades , 2001, Nature.

[111]  J. Schlessinger.  Cell Signaling by Receptor Tyrosine Kinases , 2000, Cell.

[112]  D. Cooper,et al.  Characteristics of the Ca2+‐dependent inhibition of cyclic AMP accumulation by histamine and thapsigargin in human U373 MG astrocytoma cells , 2000, British journal of pharmacology.

[113]  P. Cohen,et al.  Specificity and mechanism of action of some commonly used protein kinase inhibitors. , 2000, The Biochemical journal.

[114]  J. Guillou,et al.  Inhibition by Calcium of Mammalian Adenylyl Cyclases* , 1999, The Journal of Biological Chemistry.

[115]  J. Gutkind,et al.  Novel Molecular Mediators in the Pathway Connecting G-protein-coupled Receptors to MAP Kinase Cascades , 1999, Trends in Endocrinology & Metabolism.

[116]  J. Hurley.  Structure, Mechanism, and Regulation of Mammalian Adenylyl Cyclase* , 1999, The Journal of Biological Chemistry.

[117]  A. Ullrich,et al.  EGF receptor transactivation by G-protein-coupled receptors requires metalloproteinase cleavage of proHB-EGF , 1999, Nature.

[118]  S. Bagrodia,et al.  Cytoskeletal Reorganization by G Protein-Coupled Receptors Is Dependent on Phosphoinositide 3-Kinase γ, a Rac Guanosine Exchange Factor, and Rac , 1998, Molecular and Cellular Biology.

[119]  J. Pin,et al.  Utiliser un recepteur coupl aux protines G pour communiquer. Un succs volutif , 1998 .

[120]  R Jaffard,et al.  Ca2+-sensitive adenylyl cyclases, key integrators of cellular signalling. , 1998, Life sciences.

[121]  J. Gutkind.  The Pathways Connecting G Protein-coupled Receptors to the Nucleus through Divergent Mitogen-activated Protein Kinase Cascades* , 1998, The Journal of Biological Chemistry.

[122]  J. Thorner,et al.  RGS Proteins and Signaling by Heterotrimeric G Proteins* , 1997, The Journal of Biological Chemistry.

[123]  A. Ullrich,et al.  Role of transactivation of the EGF receptor in signalling by G-protein-coupled receptors , 1996, Nature.

[124]  R. Sunahara,et al.  Complexity and diversity of mammalian adenylyl cyclases. , 1996, Annual review of pharmacology and toxicology.

[125]  N. Mons,et al.  Adenylyl cyclases and the interaction between calcium and cAMP signalling , 1995, Nature.

[126]  A. Nordheim,et al.  Activation of ternary complex factor Elk‐1 by MAP kinases. , 1993, The EMBO journal.

[127]  P C Sternweis,et al.  Regulation of purified subtypes of phosphatidylinositol-specific phospholipase C beta by G protein alpha and beta gamma subunits. , 1993, The Journal of biological chemistry.

[128]  R. Treisman,et al.  The SRF accessory protein Elk-1 contains a growth factor-regulated transcriptional activation domain , 1993, Cell.

[129]  Richard Treisman,et al.  Functional analysis of a growth factor-responsive transcription factor complex , 1993, Cell.

[130]  M. Berridge.  Inositol trisphosphate and calcium signalling , 1993, Nature.

[131]  H. Yamane,et al.  Covalent modifications of G-proteins. , 1993, Annual review of pharmacology and toxicology.

[132]  A. Gilman,et al.  Activation of phospholipase C-beta 2 mutants by G protein alpha q and beta gamma subunits. , 1993, The Journal of biological chemistry.

[133]  J. Schlessinger,et al.  Signaling by Receptor Tyrosine Kinases , 1993 .

[134]  J. Boyer,et al.  Beta gamma-subunit activation of G-protein-regulated phospholipase C. , 1992, The Journal of biological chemistry.

[135]  A. Gilman,et al.  Type-specific regulation of adenylyl cyclase by G protein beta gamma subunits. , 1991, Science.

[136]  K. Biemann,et al.  Structure of FR900359, a cyclic depsipeptide from Ardisia crenata sims , 1988 .

[137]  A. Gilman,et al.  G proteins: transducers of receptor-generated signals. , 1987, Annual review of biochemistry.

[138]  T. Katada,et al.  Direct modification of the membrane adenylate cyclase system by islet-activating protein due to ADP-ribosylation of a membrane protein. , 1982, Proceedings of the National Academy of Sciences of the United States of America.

[139]  D. Cassel,et al.  Mechanism of cholera toxin action: covalent modification of the guanyl nucleotide-binding protein of the adenylate cyclase system. , 1978, Proceedings of the National Academy of Sciences of the United States of America.